RMNI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
RMNI is not a good buy right now for an impatient investor. The stock is in a clear downtrend (bearish moving averages and worsening MACD), and the most actionable flow signal in your dataset is heavy insider selling (up 2199% last month). While RSI is deeply oversold and could produce a short-lived bounce, there is no Intellectia buy signal to justify stepping in immediately, and an earnings event (2026-02-19) adds near-term gap risk. Net: avoid/stand aside rather than buy today.
Trend and momentum are bearish. Price $3.42 is sitting at/just below S1 (~3.424) with next support S2 ~3.304; resistance levels to reclaim are pivot 3.619 then R1 3.814. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), confirming a sustained downtrend. MACD histogram (-0.0381) is below zero and expanding negatively (downside momentum increasing). RSI(6) at 18.18 signals extreme oversold conditions—this can spark a reflex rally, but in a strong downtrend oversold can persist.
Intellectia Proprietary Trading Signals
Pattern-based trend odds also lean negative (next month expectation -1.54%), reinforcing that the dominant edge is still down rather than a clean reversal setup.
Partnership expansion: Ypêa expanding its Rimini Street partnership to enhance AI innovation and reduce software support costs (positive customer proof-point).
Event catalyst: Q4/FY2025 earnings on 2026-02-19 after hours could reset expectations if results/guide surprise to the upside.
Call-skewed open interest suggests some investors are positioned for upside.
Insider behavior: insiders are selling aggressively (selling amount up ~2199% over the last month), a strong negative sentiment signal.
Technical setup: confirmed downtrend with weakening MACD; oversold can stay oversold in bear trends.
Earnings risk: elevated IV and upcoming earnings increase the probability of a sharp gap move against a new buyer.
Short-term statistical outlook is weak (next-month pattern expectation negative).
Latest reported quarter: 2025/Q3. Revenue declined to $103.43M (-1.19% YoY), indicating modest top-line contraction. Profitability deteriorated sharply: Net income $2.77M (-106.42% YoY) and EPS $0.03 (-106.38% YoY), suggesting a major YoY earnings step-down. Gross margin also slipped to 59.89% (-1.33% YoY). Overall: soft revenue trend and significantly weaker YoY earnings momentum heading into the upcoming Q4/FY2025 report.
No analyst rating/price target change data was provided in the dataset, so the recent trend in ratings/targets cannot be quantified here. Using the available evidence to approximate the Street-style debate: Pros—customer partnership expansion and call-heavy OI can be interpreted as upside positioning into a catalyst. Cons—clear technical downtrend, weakening fundamentals in 2025/Q3, and notably heavy insider selling (a common 'pros would cite as a red flag'). Net Wall Street-style read from your data leans negative until price action and earnings trajectory improve.
